Maeda A, Kurosaki M, Ono M, Takai T, Kurosaki T
Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570, Japan.
J Exp Med. 1998 Apr 20;187(8):1355-60. doi: 10.1084/jem.187.8.1355.
Paired immunoglobulin-like receptor B (PIR-B) (p91) molecule has been proposed to function as an inhibitory receptor in B cells and myeloid lineage cells. We demonstrate here that the cytoplasmic region of PIR-B is capable of inhibiting B cell activation. Mutational analysis of five cytoplasmic tyrosines indicate that tyrosine 771 in the motif VxYxxL plays the most crucial role in mediating the inhibitory signal. PIR-B-mediated inhibition was markedly reduced in the SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 double-deficient DT40 B cells, whereas this inhibition was unaffected in the inositol polyphosphate 5'-phosphatase SHIP-deficient cells. These data demonstrate that PIR-B can negatively regulate B cell receptor activation and that this PIR-B-mediated inhibition requires redundant functions of SHP-1 and SHP-2.
配对免疫球蛋白样受体B(PIR-B)(p91)分子被认为在B细胞和髓系细胞中作为抑制性受体发挥作用。我们在此证明,PIR-B的胞质区能够抑制B细胞活化。对五个胞质酪氨酸的突变分析表明,基序VxYxxL中的酪氨酸771在介导抑制信号中起最关键作用。在含SH2结构域的蛋白酪氨酸磷酸酶SHP-1和SHP-2双缺陷的DT40 B细胞中,PIR-B介导的抑制作用明显降低,而在肌醇多磷酸5'-磷酸酶SHIP缺陷的细胞中,这种抑制作用不受影响。这些数据表明,PIR-B可以负向调节B细胞受体活化,并且这种PIR-B介导的抑制作用需要SHP-1和SHP-2的冗余功能。